TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma.

about

Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

P2860

Q55265767-D8B15137-3C19-4BFB-92E9-E7C622C72342 Q58691451-78D76937-6D1F-4848-BEC5-FDA8B3C4D163

P2860

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma.

Item

http://www.wikidata.org/entity/Q55644910

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

TPF induction chemotherapy inc ...... neck squamous cell carcinoma.

@en

TPF induction chemotherapy inc ...... neck squamous cell carcinoma.

@nl

type

Item

label

TPF induction chemotherapy inc ...... neck squamous cell carcinoma.

@en

TPF induction chemotherapy inc ...... neck squamous cell carcinoma.

@nl

prefLabel

TPF induction chemotherapy inc ...... neck squamous cell carcinoma.

@en

TPF induction chemotherapy inc ...... neck squamous cell carcinoma.

@nl

P1476

TPF induction chemotherapy inc ...... d neck squamous cell carcinoma

@en

P2093

Angélique Robin

http://www.w3.org/2001/XMLSchema#string

Caroline Even

http://www.w3.org/2001/XMLSchema#string

Elodie Maingot

http://www.w3.org/2001/XMLSchema#string

Emilie Boissier

http://www.w3.org/2001/XMLSchema#string

Emilie Louvet

http://www.w3.org/2001/XMLSchema#string

Jean-Charles Soria

http://www.w3.org/2001/XMLSchema#string

Julien Adam

http://www.w3.org/2001/XMLSchema#string

Ken A Olaussen

http://www.w3.org/2001/XMLSchema#string

Laura Faivre

http://www.w3.org/2001/XMLSchema#string

Marie-Charlotte Dessoliers

http://www.w3.org/2001/XMLSchema#string

P2860

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Nivolumab in previously untreated melanoma without BRAF mutation

Pembrolizumab for the treatment of non-small-cell lung cancer

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

P304

e000257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ESMOOPEN-2017-000257

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C Leduc

P577

2018-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29344407

http://www.w3.org/2001/XMLSchema#string

P932

5761289

http://www.w3.org/2001/XMLSchema#string

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma.

about

P2860

P2860

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932